Home > Haematology > ASH 2018 > Letter from the Editor

Letter from the Editor

Prof. Gert Ossenkoppele, VU University Medical Center, the Netherlands
ASH 2018
Dear Reader, To compose a selection of important papers presented at ASH is always difficult. Which to show and which to neglect? However, a selection is necessary because of the many thousands of abstracts that were presented and already survived a critical review by ASH reviewers. We tried to stick to papers that are really important for the daily clinical practice now or in the near future. Of special interest at this year’s ASH were the papers on AML. For the first time in many years, several new drugs showed up and are really practice-changing already now or will be very soon. Targeted treatment is emerging as well as immunotherapy. CAR T cell therapy is very promising and abstracts in non-Hodgkin lymphoma are also summarized in this review. Furthermore, you can...

Please login to read the full text of the article.

If you have no account yet, please register now.

Posted on